UroVital^® Complex – Helps maintain Prostate Health

Average quantities per tablet

*RDA: Recommended Daily Allowance (Directive 2008/100/CE)
**RDA Not Applicable

Cucurbita pepo L. seeds dry extract, standardized at 40% in fatty acids; Microcrystalline cellulose; Serenoa repens (Bartr.) Small., fruits d.e., standardized at 25% in fatty acids; Urtica dioica L., root d.e., standardized at 1% in beta-sitosterol; Beta-sitosterol; Maize starch (pregelatinized); Anti-binding agents: Talc and Magnesium stearate (vegetal origin); Quercetin; Green-tea [Camellia sinensis (L.) O.Kuntze], leafs d.e., standardized at 80% in polyphenols, 60% in catechins; Calcium phosphate (tribasic); Anti-binding agent: Colloidal silica (anhydrous); Lycopersicon esculentum Mill. fruits d.e., standardized at 5% in lycopene; Selenium (Seleniumenriched yeast); Vitamin E (D-alpha-tocopheryl acetate; soy by-products); Zinc citrate; Vitamin D3 (Cholecalciferol).

It is recommended to take up to three tablets per day, one tablet about an hour before lunch and two tablets together, 1 hour before dinner. Swallow whole, do not chew.

Do not take this supplement if you are hypersensitive to any of its constituents. It contains soy by-products.

If you are taking medicines, as for instance, to decrease platelet aggregation, anti-hypertensives or anti-clotting agents, consult your doctor or pharmacist before you start taking this supplement.

If you suffer from any deficiency (renal, hepatic, etc.), diabetes, clotting problems, hypertension or gastric ulcers, consult your doctor or pharmacist before you start taking this supplement.

This product is not recommended for women or children.

When taken at the recommended dosage UroVital^® Complex should not cause any unwanted side effects. However, in rare cases, this supplement may cause mild gastric upset such as gastric irritation, indigestion, flatulence, diarrhoea, nausea and headaches. These side effects are usually mild and disappear shortly after the supplement is discontinued.

The prostate gland is located below the bladder and is normally about the size of a walnut and produces the liquid component of semen (prostatic fluid) which is vital for effective reproduction. As men age, the prostate enlarges and in many cases this results in obstruction of the bladder and the production of bothersome symptoms.

In the UK alone 3.2 million men, over one third of men aged 50⁽¹⁾ and up to two thirds of men by the age of 60⁽²⁾, suffer from the symptoms of Benign Prostatic Hyperplasia (BPH).

Due to the location of the prostate, non-cancerous enlargement of the prostate (Benign Prostatic Hyperplasia – BPH) can result in squeezing of the urethra which can make it more difficult to pass urine. The symptoms of BPH which affect the lower urinary tract (bladder and urethra) are called ‘obstructive’ or ‘irritative’ symptoms and in addition a link has been highlighted⁽⁴⁾ between decreased erectile function and lower urinary tract symptoms (LUTS) associated BPH

Obstructive symptoms are caused by the prostate putting pressure on the urethra, narrowing it and making it harder to for the urine to pass. Examples of obstructive symptoms are hesitancy (difficulty starting urination), Poor stream (weaker flow of urine, taking bladder longer to empty), dribbling/leakage (towards the end of flow, urine become a slow dribble or you experience leakage) and poor emptying (not being able to completely empty the bladder).

Irritative symptoms tend to be secondary to the obstructive symptoms as the bladder needs to work harder to function normally; the bladder thickens and reduces in capacity to hold urine. Examples of irritative symptoms are frequency (passing urine more often than normal), nocturia (getting up at night to urinate) and urgency (sudden and intense need to go to the toilet immediately).

These troublesome and unpleasant changes in normal urinary function do not just impair the quality of life of patients and their families but also increase the risk of serious conditions such as acute urinary retention, hospitalisation and surgery ⁽³⁾.

View Product Factsheet

UroVital^® Complex – Natural BPH Supplement Factsheet (opens in new window)

Prescription drugs are available which either “shrink” the prostate or affect the flow of urine by acting on the prostate smooth muscle. As a result they can take some time to be effective. UroVital^® Complex has been formulated to have a rapid effect on the structures that control the flow of urine with a corresponding short time of action to improve problematic changes in urinary health.

Complementary and alternative products such as supplements have become increasingly popular as dietary health supplements for the treatment/improvement and prophylaxis of urological disorders and to improve general health and wellbeing.

UroVital^® Complex is a natural health supplement that has been formulated to specifically assist in the maintenance of prostate health and urinary tract function and is designed to be taken with prescription medicines or on their own. Each of the individual components were selected due to their potential role in the maintenance of a healthy prostate and urinary tract.

UroVital^® Complex contains ingredients which have been shown clinically to be beneficial in some patients to avoid or reduce obstructive and irritative changes to urinary health. This natural daily supplement would benefit men with changes in urinary function predominantly suggestive of an irritative condition.

UroVital^® Complex Contains:

Pumpkin seeds (Cucurbita pepo L): a rich source of natural protein, phytosterols, polyunsaturated fatty acids and vitamins, such as carotenoids and trace elements such as zinc. Pumpkin seeds have both anti-inflammatory and antiandrogen properties and have been reported to reduce symptoms associated with BPH.⁽⁵⁾

Saw Palmetto: extracts from the berries of Serenoa Repens (known as saw palmetto) are highly enriched with fatty acids and phytosterols and has antiandrogen and anti-inflammatory effects. It is the most common phototherapeutic agent used in the symptomatic treatment of BPH and has been clinically proven to reduce symptoms.⁽⁶⁾

Beta-sitosterol: a naturally occurring phytosterol with anti-inflammatory, anti-proliferation and immune system stimulation properties. It has an established benefit in the relief of symptoms associated with BPH. ⁽⁷⁾

Quercetin: a naturally occurring flavoid with known anti-inflammatory, anti-proliferation and antioxidant properties which has been reported to improve symptoms related to prostatitis.⁽⁸⁾

Nettle extract (Urtica Dioica): An anti-inflammatory effect in the prostate which has been reported to improve irritation and obstructive symptoms associated with BPH.⁽⁹⁾

Green tea (camellia sinesis L): is derived from the leaves of camellia sinesis and contains many characteristic polyphenolic compounds and antioxidants and has potential value in a range of disorders including prostate cancer.⁽¹⁰⁾

Lycopene: is a cartenoid pigment and phytochemical with antioxidant properties found in tomatoes and other red fruits and vegetables and may play a role in cancer prevention.⁽¹¹⁾

Vitamins and minerals such as zinc, selenium, vitamin E and vitamin which have been included into the formulation for beneficial effects on the prostate and urinary tract health.

1. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991; 338:469–471
2. Arrighi HM, Metter EJ, Guess HA, Fozzard JL.Natural history of benign prostatic hyperplasia and risk of prostatectomy, the Baltimore Longitudinal Study of Aging. Urology 1991; 35 (Suppl): 4-8.
3. Speakman MJ, Kirby RS, Joyce A, Abrams P, Pocock R.Guideline for the primary care management of male lower urinary tract symptoms. BJU Int 2004; 93: 985–990
4. Schiff JD and Mulhall J. The link between LUTS and ED: clinical and basic scientific evidence. J Androl 2004; 25(4): 470-8
5. Carbin B.E, Larsson B, Lindahl O. Treatment of benign prostatic hyperplasia with phytosterols. BJU 1990; 66: 639-41
6. Gerber GS, Kuznetsov D, Johnson BC, Burstein JD. Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms. Urology 2001; 58: 960–4
7. Berges RR, Windeler J, Trampish Hj, Senge J. Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol study group. Lancet 1995; 345: 1529-32
8. Shoakes OA, Zeitlin Sl, Shaded A, Raifer A. Querceting in men with category III chronic prostatitis: A preliminary prospective, double-blind, placebo controlled-trial. Urology 1999; 54: 960-3
9. Safarinejad MR. Urtica dioica for treatment of benign prostatic hyperplasia: prospective, randomized, double-blind, placebo-controlled, crossover study. J Herb Pharmacother 2005; 5:1-11
10. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancel by oral administration of Green Tea Catechins in Volunteers with High-Grade Prostate Intraepithelial Neoplasia: A Preliminary Report from a One-Year Proof of Principle Study. Cancer Res 2006; 66(2): 1234-40
11. Giovannucci E, Rimm E, Liu Y, Stampfer M, Willet WC. A Prospective Study of Tomato Products, Lycopene, and Prostate Cancer Risk. Journal National Cancer Institute. 2002; 94(5): 391-8